- Home
- MYO vs SGHT Comparison
MYO vs SGHT Comparison
Compare MYO & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYO
- SGHT
- Stock Information
- Founded
- MYO 2004
- SGHT 2011
- Country
- MYO United States
- SGHT United States
- Employees
- MYO N/A
- SGHT N/A
- Industry
- MYO Industrial Specialties
- SGHT Medical Specialities
- Sector
- MYO Health Care
- SGHT Health Care
- Exchange
- MYO Nasdaq
- SGHT Nasdaq
- Market Cap
- MYO 153.0M
- SGHT 157.7M
- IPO Year
- MYO 2017
- SGHT 2021
- Fundamental
- Price
- MYO $3.22
- SGHT $3.03
- Analyst Decision
- MYO Strong Buy
- SGHT Buy
- Analyst Count
- MYO 4
- SGHT 7
- Target Price
- MYO $9.50
- SGHT $3.92
- AVG Volume (30 Days)
- MYO 477.7K
- SGHT 163.5K
- Earning Date
- MYO 05-07-2025
- SGHT 05-08-2025
- Dividend Yield
- MYO N/A
- SGHT N/A
- EPS Growth
- MYO N/A
- SGHT N/A
- EPS
- MYO N/A
- SGHT N/A
- Revenue
- MYO $38,628,624.00
- SGHT $78,109,000.00
- Revenue This Year
- MYO $57.44
- SGHT N/A
- Revenue Next Year
- MYO $21.76
- SGHT $11.17
- P/E Ratio
- MYO N/A
- SGHT N/A
- Revenue Growth
- MYO 97.60
- SGHT N/A
- 52 Week Low
- MYO $2.76
- SGHT $2.03
- 52 Week High
- MYO $7.17
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- MYO 26.65
- SGHT 56.13
- Support Level
- MYO $4.65
- SGHT $2.81
- Resistance Level
- MYO $4.87
- SGHT $3.26
- Average True Range (ATR)
- MYO 0.28
- SGHT 0.24
- MACD
- MYO -0.11
- SGHT -0.01
- Stochastic Oscillator
- MYO 3.28
- SGHT 38.57
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.